Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
6.68
+3.68 (122.30%)
At close: Dec 17, 2025, 4:00 PM EST
4.290
-2.390 (-35.78%)
Pre-market: Dec 18, 2025, 9:10 AM EST
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $15.14 million as of December 18, 2025. Its market cap has increased by 298.30% in one year.
Market Cap
15.14M
Enterprise Value
8.83M
1-Year Change
298.30%
Ranking
Category
Stock Price
$6.68
Market Cap Chart
Since October 2, 2020, Processa Pharmaceuticals's market cap has decreased from $34.40M to $15.14M, a decrease of -56.00%. That is a compound annual growth rate of -14.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 6.80M | 134.48% |
| Dec 31, 2024 | 2.90M | -64.63% |
| Dec 29, 2023 | 8.20M | -53.41% |
| Dec 30, 2022 | 17.60M | -77.14% |
| Dec 31, 2021 | 77.00M | 10.47% |
| Dec 31, 2020 | 69.70M | 102.62% |
| Oct 2, 2020 | 34.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |